Bigdeli, Tim B. http://orcid.org/0000-0003-2215-5946
Barr, Peter B. http://orcid.org/0000-0001-9321-657X
Rajeevan, Nallakkandi
Graham, David P.
Li, Yuli
Meyers, Jacquelyn L. http://orcid.org/0000-0003-3863-8555
Gorman, Bryan R. http://orcid.org/0000-0002-4239-4672
Peterson, Roseann E.
Sayward, Frederick
Radhakrishnan, Krishnan
Natarajan, Sundar
Nielsen, David A. http://orcid.org/0000-0002-2583-0233
Wilkinson, Anna V.
Malhotra, Anil K.
Zhao, Hongyu http://orcid.org/0000-0003-1195-9607
Brophy, Mary
Shi, Yunling
O’Leary, Timothy J. http://orcid.org/0000-0002-2435-9136
Gleason, Theresa
Przygodzki, Ronald http://orcid.org/0000-0002-1238-262X
Pyarajan, Saiju http://orcid.org/0000-0002-9047-3762
Muralidhar, Sumitra
Gaziano, J. Michael
Huang, Grant D.
Concato, John
Siever, Larry J.
DeLisi, Lynn E.
Kimbrel, Nathan A. http://orcid.org/0000-0001-7218-1005
Beckham, Jean C. http://orcid.org/0000-0001-8746-8949
Swann, Alan C. http://orcid.org/0000-0001-9879-6198
Kosten, Thomas R. http://orcid.org/0000-0003-1505-555X
Fanous, Ayman H.
O’Leary, Timothy J.
Gleason, Theresa
Przygodzki, Ronald
Muralidhar, Sumitra
Gaziano, Michael
Huang, Grant D.
Concato, John
DeLisi, Lynn E.
Aslan, Mihaela
Harvey, Philip D.
,
Funding for this research was provided by:
Brain and Behavior Research Foundation (28276)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01DA050721)
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (R01AA015416)
Article History
Received: 6 April 2023
Revised: 22 January 2024
Accepted: 31 January 2024
First Online: 15 March 2024
Competing interests
: PDH has served as a consultant to multiple pharmaceutical companies and device manufacturers on phase 2 or 3 development; this consulting work has been determined to be unrelated to the content of the paper. No other authors report any relevant conflicts of interest.